Head-To-Head Contrast: Inspire Medical Systems (NYSE:INSP) vs. Enovis (NYSE:ENOV)

Inspire Medical Systems (NYSE:INSP) and Enovis (NYSE:ENOV) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, valuation, analyst recommendations, profitability, institutional ownership and risk.

Analyst Ratings

This is a breakdown of current ratings and price targets for Inspire Medical Systems and Enovis, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inspire Medical Systems	3	13	4	0	2.05
Enovis	1	1	7	0	2.67

Inspire Medical Systems currently has a consensus target price of $81.84, indicating a potential upside of 98.19%. Enovis has a consensus target price of $44.50, indicating a potential upside of 87.38%. Given Inspire Medical Systems’ higher probable upside, equities analysts clearly believe Inspire Medical Systems is more favorable than Enovis.

Valuation and Earnings

This table compares Inspire Medical Systems and Enovis”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Inspire Medical Systems	$911.98 million	1.30	$145.42 million	$4.49	9.20
Enovis	$2.25 billion	0.61	-$1.18 billion	($19.88)	-1.19

Inspire Medical Systems has higher earnings, but lower revenue than Enovis. Enovis is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Inspire Medical Systems and Enovis’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Inspire Medical Systems	14.33%	10.35%	8.81%
Enovis	-49.92%	10.32%	4.57%

Risk & Volatility

Inspire Medical Systems has a beta of 0.73, meaning that its stock price is 27% less volatile than the S&P 500. Comparatively, Enovis has a beta of 1.38, meaning that its stock price is 38% more volatile than the S&P 500.

Insider & Institutional Ownership

94.9% of Inspire Medical Systems shares are owned by institutional investors. Comparatively, 98.5% of Enovis shares are owned by institutional investors. 2.2% of Inspire Medical Systems shares are owned by insiders. Comparatively, 2.9% of Enovis shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

Inspire Medical Systems beats Enovis on 8 of the 14 factors compared between the two stocks.

About Inspire Medical Systems

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

About Enovis

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.